Exploratory Clinical Study on YTS109 Cell Therapy for Autoimmune Diseases

Clinical trial NCT07236801 · RECRUITING

Trial details

NCT number: NCT07236801
Sponsor: China Immunotech (Beijing) Biotechnology Co., Ltd.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Systemic Lupus Erythematosus (SLE)Systemic Sclerosis Sjogren's Syndrome (SS)Inflammatory Myopathy Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis Antiphospholipid Syndrome

Start date: 2025-11-13
Primary completion: 2026-11-13
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.